Long Term Use of Reglan Leads to Rising Number of Lawsuits

Use of the gastrointestinal drug Reglan, and other generic drugs containing Metoclopramide, can cause a disabling neurological syndrome known as Reglan tardive dyskinesia, which involves involuntary and repetitive movements that can be permanent. These Reglan neurological problems are devastating and socially disabling, causing severe physical, mental, social and emotional suffering. In February 2009, the U.S. Food & Drug Administration (FDA) mandated that the makers of Reglan add a black box warning to its label regarding the risk of tardive dyskinesia associated with chronic, long-term use. The FDA’s mandate followed the publication of analyses that suggested that Reglan is the most common cause of drug-induced movement disorders. 

To prevent tardive dyskinesia and other Reglan side effects, the drug should not be taken for more than 12 months, and it has not been approved for longer user. However, it has become

Reglan Settlements Possible Over Neurological Movement Disorders

Reglan is a relatively harmless drug when it is taken for a brief period of time. It is used to treat gastrointestinal conditions that make it difficult to digest food or keep food down, and can help people with certain types of diabetes and even morning sickness from pregnancy. If a patient takes the medication for twelve weeks or less, there is a relatively low rate of Reglan side effects experienced by the patient. However, almost one in three Reglan patients take the medication for much longer than twelve weeks—and these patients are much more likely to suffer from debilitating and painful side effects.

Reglan side effects usually involve Reglan neurological problems, the most common of which is tardive dyskinesia. The symptoms of Reglan tardive dyskinesia include, but are not limited to, spasms and tics of the facial area, which are involuntary. Lip puckering, protrusions of the tongue, and rapid eye blinking are telltale signs of tardive dyskinesia.

Reglan Lawsuits Over Tardive Dyskinesia

Lawsuit filed against Reglan by Reglan lawyer. There are more than 2 million American patients still using the controversial gastrointestinal drug Reglan, which contains a chemical discovered in the 1960s but was shelved in a backseat position after a competing drug was discovered in the 1990s. After that drug, Cisapride, was discontinued because it was linked to cardiac arrhythmia, Reglan was pushed to the forefront once again. Now the drug is in the media for another time, because of Reglan side effects in children —namely, tardive dyskinesia, a movement disorder that affects the muscles in the face and limbs.

Reglan neurological problems: Patients with tardive dyskinesia often will not be able to find a treatment because there is no confirmed treatment or cure for the condition.